Drug Shortage Report for XERESE
Report ID | 23233 |
Drug Identification Number | 02404044 |
Brand name | XERESE |
Common or Proper name | XERESE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ACYCLOVIR HYDROCORTISONE |
Strength(s) | 5% 1% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL |
Packaging size | n/a |
ATC code | D06BB |
ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-10-31 |
Actual start date | |
Estimated end date | 2018-02-28 |
Actual end date | 2018-02-12 |
Shortage status | Resolved |
Updated date | 2018-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-25 | English | Compare |
v2 | 2017-09-25 | French | Compare |
v3 | 2017-09-25 | English | Compare |
v4 | 2017-09-25 | French | Compare |
v5 | 2017-11-01 | English | Compare |
v6 | 2018-01-23 | English | Compare |
v7 | 2018-01-23 | French | Compare |
v8 | 2018-02-12 | English | Compare |
v9 | 2018-02-12 | French | Compare |
v10 | 2018-02-13 | English | Compare |
Showing 1 to 10 of 10